Like other industries, Biotech and Pharma are viewing the Trump administration with some trepidation. One concern – among many – is whether job cuts instituted by the US’s Department of Government Efficiency (DOGE), led by Elon Musk, will slow down the rate of drug approvals. Among the agencies hit are the Food and Drugs Administration […]
MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus and Wacker Biotech, a contract development and manufacturing organisation, on Tuesday announced a collaboration to manufacture the active protein ingredients of MinervaX’s GBS vaccine. MinervaX will scale up supply of its novel GBS vaccine, ahead of commencing phase […]
Novo Holdings, a leading healthcare investment firm, announced today its acquisition of KabaFusion (the “Company”), a leading national provider of home infusion therapies, from Pritzker Private Capital (“PPC”), a leader in family direct investing. Terms of the transaction were not disclosed. Read more here.
